Technical Analysis for MDWD - MediWound Ltd.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Down | Down |
| Historical MDWD trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Stochastic Reached Oversold | Weakness | 0.00% | |
| Below Lower BB | Weakness | 0.00% | |
| Down 3 Days in a Row | Weakness | 0.00% | |
| Down 4 Days in a Row | Weakness | 0.00% | |
| Down 5 Days in a Row | Weakness | 0.00% | |
| Lower Bollinger Band Touch | Weakness | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Down 3 Days in a Row | Weakness | -2.70% | |
| Down 4 Days in a Row | Weakness | -2.70% | |
| Narrow Range Bar | Range Contraction | -4.48% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
| Alert | Time |
|---|---|
| Up 2% | 1 day ago |
| Up 1% | 1 day ago |
| Lower Bollinger Band Support | 2 days ago |
| Down 2 % | 2 days ago |
| Fell Below Previous Day's Low | 2 days ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 02/25/2021
MediWound Ltd., an integrated biopharmaceutical company, focuses on developing, manufacturing, and commercializing products for the treatment of severe burns, chronic and other hard-to-heal wounds, and connective tissue disorders. Its lead product candidate is EscharEx, which is in Phase II clinical trials for the debridement of chronic and other hard-to-heal wounds. The company is also developing NexoBrid for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns. MediWound Ltd. was incorporated in 2000 and is headquartered in Yavne, Israel.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Clinical Medicine Wound Burns Acute Pain Medical Emergencies Connective Tissue Necrosis Debridement Yavne
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Clinical Medicine Wound Burns Acute Pain Medical Emergencies Connective Tissue Necrosis Debridement Yavne
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 6.07 |
| 52 Week Low | 1.7299 |
| Average Volume | 112,297 |
| 200-Day Moving Average | 4.24 |
| 50-Day Moving Average | 5.34 |
| 20-Day Moving Average | 5.11 |
| 10-Day Moving Average | 5.08 |
| Average True Range | 0.31 |
| ADX | 14.87 |
| +DI | 9.99 |
| -DI | 24.74 |
| Chandelier Exit (Long, 3 ATRs ) | 4.82 |
| Chandelier Exit (Short, 3 ATRs ) | 5.43 |
| Upper Bollinger Band | 5.49 |
| Lower Bollinger Band | 4.72 |
| Percent B (%b) | -0.04 |
| BandWidth | 15.19 |
| MACD Line | -0.11 |
| MACD Signal Line | -0.06 |
| MACD Histogram | -0.0518 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 5.38 | ||||
| Resistance 3 (R3) | 5.39 | 5.18 | 5.26 | ||
| Resistance 2 (R2) | 5.18 | 5.00 | 5.17 | 5.23 | |
| Resistance 1 (R1) | 4.93 | 4.89 | 4.82 | 4.92 | 5.19 |
| Pivot Point | 4.72 | 4.72 | 4.66 | 4.71 | 4.72 |
| Support 1 (S1) | 4.47 | 4.54 | 4.37 | 4.46 | 4.19 |
| Support 2 (S2) | 4.26 | 4.43 | 4.25 | 4.15 | |
| Support 3 (S3) | 4.01 | 4.26 | 4.12 | ||
| Support 4 (S4) | 4.00 |
